Metastatic neuroendocrine carcinoma
Clinical trials for Metastatic neuroendocrine carcinoma explained in plain language.
Never miss a new study
Get alerted when new Metastatic neuroendocrine carcinoma trials appear
Sign up with your email to follow new studies for Metastatic neuroendocrine carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for tough cancers
Disease control OngoingThis early-phase trial tests a new drug called BAY 1895344 combined with standard chemotherapy (irinotecan or topotecan) in people with advanced solid tumors, especially small cell lung cancer, poorly differentiated neuroendocrine cancer, and pancreatic cancer. The goal is to fin…
Matched conditions: METASTATIC NEUROENDOCRINE CARCINOMA
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New Vaccine-Chemo combo shows promise for Tough-to-Treat tumors
Disease control PausedThis study tests whether adding a vaccine called SurVaxM to the chemotherapy drug temozolomide can help control advanced neuroendocrine tumors that are growing. About 60 adults with these rare cancers will receive either the combination or chemo alone. The goal is to see if the v…
Matched conditions: METASTATIC NEUROENDOCRINE CARCINOMA
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Triple-Drug cocktail shows promise against rare neuroendocrine tumors
Disease control OngoingThis phase 2 trial is testing a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—in 17 people with advanced neuroendocrine cancer that has spread. The goal is to see if the combination can shrink tumors or stop them from growing. Cabozantinib blocks enzymes that…
Matched conditions: METASTATIC NEUROENDOCRINE CARCINOMA
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC